1. Agence de la BioMedecine (ABM), 2020https://www.agence-biomedecine.fr/ (15th April date last accessed)
2. American Society of Reproductive Medicine. Patient management and clinical recommendations during coronavirus (COVID-19) pandemic. Second update published 13th April 2020ahttps://www.asrm.org/blobalassets/asrm/asrm-content/news-and-publications/COVIDtaskforce.pdf. Link does not work
3. American Society of Reproductive Medicine Issues New guidance on fertility care during COVID-19 Pandemic: Calls for suspension of most treatments. 2020bhttps://www.asrm.org/news-and-publications/news-and-research/press-releases-and-bulletins/asrm-issues-new-guidance-on-fertility-care-during-COVID-19-pandemiccalls-for-suspension-of-most-treatments/ (15th April date last accessed)
4. ASEBIR, RECOMENDACIONES ASEBIR frente al SARS-CoV-2.https://asebir.com/recomendaciones-asebir-frente-al-sars-cov-2/ 2020 (15th April date last accessed)
5. British Fertility Society / Association of Reproductive & Clinical Scientists, Guidance for the care of fertility patients during the Coronavirus COVID 19 Pandemic.https://www.britishfertilitysociety.org.uk/2020/03/18/guidance-for-the-care-of-fertility-patients-during-the-coronavirus-COVID-19-pandemic/ (15th April date last accessed)